Trial Profile
Phase I Dose-Escalation Trial of Clofarabine Followed by Escalating Doses of Fractionated Cyclophosphamide in Children With Relapsed or Refractory Acute Leukemias.
Status:
Discontinued
Phase of Trial:
Phase I
Latest Information Update: 09 Nov 2021
Price :
$35
*
At a glance
- Drugs Clofarabine (Primary) ; Cyclophosphamide (Primary)
- Indications Leukaemia
- Focus Adverse reactions
- 13 Feb 2018 Status changed from active, no longer recruiting to discontinued.
- 21 Sep 2010 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 02 Mar 2009 New trial record